Go Pro
→ Your $29.97 book is free today (From Profits Run) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
$234.19
-2.5%		$228.37
$145.47
▼
$258.30
$54.85B0.492.04 million shs1.91 million shs
Cencora, Inc. stock logo
COR
Cencora
$313.24
-6.2%		$296.42
$244.82
▼
$377.54
$60.94B0.571.55 million shs2.61 million shs
McKesson Corporation stock logo
MCK
McKesson
$877.21
-2.7%		$806.83
$659.86
▼
$999.00
$102.27B0.3953,822 shs1.09 million shs
7 Stocks That Will Be Magnificent in 2026 Cover
7 Stocks That Will Be Magnificent in 2026

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
+1.40%+2.90%+1.93%+28.81%+51.89%
Cencora, Inc. stock logo
COR
Cencora
+2.79%+8.80%+9.86%+30.37%+14.59%
McKesson Corporation stock logo
MCK
McKesson
+2.69%+8.39%+11.96%+22.41%+33.83%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
$234.19
-2.5%		$228.37
$145.47
▼
$258.30
$54.85B0.492.04 million shs1.91 million shs
Cencora, Inc. stock logo
COR
Cencora
$313.24
-6.2%		$296.42
$244.82
▼
$377.54
$60.94B0.571.55 million shs2.61 million shs
McKesson Corporation stock logo
MCK
McKesson
$877.21
-2.7%		$806.83
$659.86
▼
$999.00
$102.27B0.3953,822 shs1.09 million shs
7 Stocks That Will Be Magnificent in 2026 Cover
7 Stocks That Will Be Magnificent in 2026

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
+1.40%+2.90%+1.93%+28.81%+51.89%
Cencora, Inc. stock logo
COR
Cencora
+2.79%+8.80%+9.86%+30.37%+14.59%
McKesson Corporation stock logo
MCK
McKesson
+2.69%+8.39%+11.96%+22.41%+33.83%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
2.83
Moderate Buy$260.479.98% Upside
Cencora, Inc. stock logo
COR
Cencora
2.87
Moderate Buy$374.2517.05% Upside
McKesson Corporation stock logo
MCK
McKesson
2.82
Moderate Buy$977.0010.51% Upside

Current Analyst Ratings Breakdown

Latest CAH, MCK, and COR Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/12/2026
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
Morgan Stanley logo
Morgan Stanley
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetOverweight$255.00 ➝ $265.00
8/12/2026
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
Evercore Inc logo
Evercore
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingOutperform$270.00
8/12/2026
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
UBS Group AG logo
UBS Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetBuy$274.00 ➝ $280.00
8/12/2026
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
Mizuho logo
Mizuho
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetOutperform$240.00 ➝ $250.00
8/12/2026
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
Wells Fargo & Company logo
Wells Fargo & Company
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetOverweight$245.00 ➝ $277.00
8/12/2026
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
Robert W. Baird logo
Robert W. Baird
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetOutperform$251.00 ➝ $274.00
8/11/2026
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
Leerink Partners logo
Leerink Partners
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Set Price Target$292.00
8/11/2026
Cencora, Inc. stock logo
COR
Cencora
Wells Fargo & Company logo
Wells Fargo & Company
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetOverweight$331.00 ➝ $395.00
8/11/2026
McKesson Corporation stock logo
MCK
McKesson
Wells Fargo & Company logo
Wells Fargo & Company
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetEqual Weight$812.00 ➝ $933.00
8/7/2026
McKesson Corporation stock logo
MCK
McKesson
Morgan Stanley logo
Morgan Stanley
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingOverweight
8/7/2026
Cencora, Inc. stock logo
COR
Cencora
Morgan Stanley logo
Morgan Stanley
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetOverweight$342.00 ➝ $346.00
(Data available from 8/12/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
$222.58B0.25$11.65 per share20.33($11.04) per share-21.45
Cencora, Inc. stock logo
COR
Cencora
$638.56M97.42$21.26 per share15.04$16.65 per share19.20
McKesson Corporation stock logo
MCK
McKesson
$410.98B0.25$45.78 per share19.31($33.14) per share-26.68
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
$1.56B$6.5436.2119.671.160.62%-92.61%4.46%N/A
Cencora, Inc. stock logo
COR
Cencora
$1.55B$13.4623.7516.171.870.79%125.45%4.18%N/A
McKesson Corporation stock logo
MCK
McKesson
$4.76B$37.3723.6617.771.731.12%-253.21%5.90%N/A

Latest CAH, MCK, and COR Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/11/2026Q4 2026
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
$2.42$2.91+$0.49$1.70$65.15 billion$63.67 billion
8/5/2026Q3 2026
Cencora, Inc. stock logo
COR
Cencora
$4.35$4.48+$0.13$3.94$84.31 billion$84.75 billion
8/5/2026Q1 2027
McKesson Corporation stock logo
MCK
McKesson
$9.56$9.93+$0.37$5.15$103.88 billion$105.38 billion
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
$2.060.87%+1.02%31.50%29 Years
Cencora, Inc. stock logo
COR
Cencora
$2.400.75%+5.79%17.83%15 Years
McKesson Corporation stock logo
MCK
McKesson
$3.760.43%+13.68%10.06%17 Years

Latest CAH, MCK, and COR Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
8/10/2026
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
quarterly$0.51580.86%10/1/202610/1/202610/15/2026
7/21/2026
McKesson Corporation stock logo
MCK
McKesson
quarterly$0.940.46%9/1/20269/1/202610/1/2026
8/3/2026
Cencora, Inc. stock logo
COR
Cencora
quarterly$0.600.76%8/14/20268/14/20268/31/2026
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
N/A
0.91
0.48
Cencora, Inc. stock logo
COR
Cencora
3.53
0.93
0.58
McKesson Corporation stock logo
MCK
McKesson
N/A
0.89
0.52

Institutional Ownership

CompanyInstitutional Ownership
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
87.17%
Cencora, Inc. stock logo
COR
Cencora
97.52%
McKesson Corporation stock logo
MCK
McKesson
85.07%

Insider Ownership

CompanyInsider Ownership
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
0.12%
Cencora, Inc. stock logo
COR
Cencora
0.38%
McKesson Corporation stock logo
MCK
McKesson
0.06%
CompanyEmployeesShares OutstandingFree FloatOptionable
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
57,700234.21 million233.93 millionOptionable
Cencora, Inc. stock logo
COR
Cencora
51,000194.56 million193.82 millionOptionable
McKesson Corporation stock logo
MCK
McKesson
43,000116.59 million116.52 millionOptionable

Recent News About These Companies

McKesson (MCK) Gets a Buy from J.P. Morgan
 |  theglobeandmail.comhttps://www.theglobeandmail.com/investing/markets/stocks/MCK-N/pressreleases/3802181/mckesson-mck-gets-a-buy-from-j-p-morgan/
Cardinal Health branded boxes on pallets sit amid automated conveyor systems in a distribution warehouse.
Cardinal Health Earnings: Can Perfection Get Priced In Twice? (MCK)
...
 |  marketbeat.comhttps://www.marketbeat.com/articles/cardinal-health-earnings-can-perfection-get-priced-in-twice/
Wedge Capital Management L L P NC Has $29.42 Million Position in McKesson Corporation $MCK
August 12 at 7:03 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-wedge-capital-management-l-l-p-nc-has-2942-million-position-in-mckesson-corporation-mck-2026-08-12/
Citi Keeps Their Buy Rating on McKesson (MCK)
August 12 at 4:34 AM  |  theglobeandmail.comhttps://www.theglobeandmail.com/investing/markets/stocks/MCK/pressreleases/3788863/citi-keeps-their-buy-rating-on-mckesson-mck/
What Does McKesson’s (NYSE:MCK) $105B Quarter Mean for S&P 500 Investors?
August 12 at 4:34 AM  |  kalkinemedia.comK
McKesson (NYSE:MCK) Director Sells $268,591.33 in Stock
August 11 at 3:06 PM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/mckesson-nysemck-director-sells-26859133-in-stock-2026-08-11/
McKesson Corp. stock underperforms Monday when compared to competitors despite daily gains
August 11 at 12:25 PM  |  marketwatch.comhttps://www.marketwatch.com/data-news/mckesson-corp-stock-underperforms-monday-when-compared-to-competitors-despite-daily-gains-de2c18d3-025b6f92fdea
S&P 500 Medical Stocks: Three Trade Near Buy Points; One Rallies Despite Mixed Results
August 11 at 12:25 PM  |  finance.yahoo.comhttps://finance.yahoo.com/m/c936783e-315d-3ad2-9bd9-efb645974d94/s%26p-500-medical-stocks%3A-three.html
McKesson (NYSE:MCK) Given New $933.00 Price Target at Wells Fargo & Company
August 11 at 9:23 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/mckesson-nysemck-given-new-93300-price-target-at-wells-fargo-company-2026-08-11/
Handelsbanken Fonder AB Cuts Stock Holdings in McKesson Corporation $MCK
August 11 at 6:31 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-handelsbanken-fonder-ab-cuts-stock-holdings-in-mckesson-corporation-mck-2026-08-11/
E. Ohman J or Asset Management AB Boosts Stock Position in McKesson Corporation $MCK
August 11 at 4:24 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-e-ohman-j-or-asset-management-ab-boosts-stock-position-in-mckesson-corporation-mck-2026-08-11/
Integer Holdings Q2 Earnings & Revenues Top Estimates, Margins Decline
August 10 at 3:01 PM  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/integer-holdings-q2-earnings-revenues-172700785.html
QDEL Q2 Earnings & Revenues Beat Estimates, 2026 Guidance Lowered
August 10 at 3:01 PM  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/qdel-q2-earnings-revenues-beat-172900707.html
Here's Why McKesson (MCK) is a Strong Momentum Stock
August 10 at 10:50 AM  |  zacks.comhttps://www.zacks.com/stock/news/2971868/here-s-why-mckesson-mck-is-a-strong-momentum-stock?cid=cs-stocknewsapi-ft-fundamental_analysis|zacks_education_momentum_score-2971868
6,734 Shares in McKesson Corporation $MCK Bought by Deane Retirement Strategies Inc.
August 10 at 4:07 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-6734-shares-in-mckesson-corporation-mck-bought-by-deane-retirement-strategies-inc-2026-08-10/
McKesson Corporation $MCK Shares Acquired by Hennion & Walsh Asset Management Inc.
August 9 at 6:07 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-mckesson-corporation-mck-shares-acquired-by-hennion-walsh-asset-management-inc-2026-08-09/
McKesson Corporation $MCK Shares Sold by Assenagon Asset Management S.A.
August 9 at 3:27 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-mckesson-corporation-mck-shares-sold-by-assenagon-asset-management-sa-2026-08-09/
McKesson Q1 Earnings Call Highlights
August 8, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/mckesson-q1-earnings-call-highlights-2026-08-08/
How Higher Sales, Lower EPS And New Guidance At McKesson (MCK) Has Changed Its Investment Story
August 8, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/markets/stocks/articles/higher-sales-lower-eps-guidance-091137498.html
McKesson: Solid Q1 Earnings And Management Execution (Rating Upgrade)
August 8, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4933701-mckesson-solid-q1-earnings-and-management-execution-upgrade?utm_source=marketbeat.com&utm_medium=referral&feed_item_type=article?source=MarketBeat
Bank of America Securities Reaffirms Their Buy Rating on McKesson (MCK)
August 7, 2026  |  theglobeandmail.comhttps://www.theglobeandmail.com/investing/markets/stocks/MCK/pressreleases/3717161/bank-of-america-securities-reaffirms-their-buy-rating-on-mckesson-mck/

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
McKesson distribution facility exterior at dusk, showing branded trucks at loading docks and a glass-walled warehouse interior.
McKesson's Compounding Keeps Adding Up
By Peter Frank | July 31, 2026
Aerial view of an industrial power plant and adjacent facility with the NextEra Energy logo overlaid.
Powering Up: NextEra and Brookfield Build an Off-Grid Empire
By Jeffrey Neal Johnson | July 30, 2026
Desk scene with a tablet showing an upward stock chart, prescription pill bottles, financial reports, and a coffee mug.
3 Healthcare Stocks With Fresh Dividend Hikes and Different Income Profiles
By Leo Miller | August 3, 2026
Row of illuminated server racks with blue lighting in a data center, reflecting on the polished floor.
AMD’s Helios Launch Could Create Winners Beyond AMD Stock
By Thomas Hughes | August 11, 2026
Cardinal Health branded boxes on pallets sit amid automated conveyor systems in a distribution warehouse.
Cardinal Health Earnings: Can Perfection Get Priced In Twice?
By Chris Markoch | August 12, 2026
Cardinal Health stock logo

Cardinal Health NYSE:CAH

$234.19 -6.07 (-2.53%)
As of 03:58 PM Eastern

Cardinal Health, Inc. operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. The company operates in two segments, Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. The segment also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; operates nuclear pharmacies and radiopharmaceutical manufacturing facilities; repackages generic pharmaceuticals and over-the-counter healthcare products; and provides pharmacy management services to hospitals. The Medical segment manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe, and sharps disposals; compressions; incontinences; nutritional delivery products; wound care products; single-use surgical drapes, gowns, and apparels; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. The segment also distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile, and non-sterile procedure kits. The company was incorporated in 1979 and is headquartered in Dublin, Ohio.

Cencora stock logo

Cencora NYSE:COR

$313.24 -20.63 (-6.18%)
As of 03:58 PM Eastern

Cencora, Inc. sources and distributes pharmaceutical products. The company's U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to various institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and additional services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; and sales force services to manufacturers. This segment also distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; and provides other services to physicians who specialize in various disease states, such as oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. Its International Healthcare Solutions segment offers international pharmaceutical wholesale and related service, and global commercialization services; distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers, and hospitals primarily in Europe; and provides specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was incorporated in 2001 and is headquartered in Conshohocken, Pennsylvania.

McKesson stock logo

McKesson NYSE:MCK

$877.21 -24.56 (-2.72%)
As of 03:58 PM Eastern

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products. This segment also offers practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The RxTS segment serves biopharma and life sciences partners, and patients to address medication challenges for patients by working across healthcare; connects patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies to deliver innovative solutions to help people get the medicine needed to live healthier lives; and provides prescription price transparency, benefit insight, dispensing support, third-party logistics, and wholesale distribution support services. The Medical-Surgical Solutions segment offers medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, nursing homes, hospital reference labs, and home health care agencies. The International segment provides distribution and services to wholesale, institutional, and retail customers in Europe and Canada. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas